COMMD8
gene geneOn this page
Also known as FLJ20502
Summary
COMMD8 (COMM domain containing 8, HGNC:26036) is a protein-coding gene on chromosome 4p12, encoding COMM domain-containing protein 8 (Q9NX08). Scaffold protein in the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of the CCC subcomplex and the retriever subcomplex. It is a selective cancer dependency (DepMap: 11.4% of cell lines).
The protein encoded by this gene binds coiled-coil domain-containing protein 22 (CCDC22), and this complex can regulate the turnover of I-kappa-B and the activation of NF-kappa-B.
Source: NCBI Gene 54951 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 40 total
- GTEx eGene: eQTL in 16 tissues, sQTL in 5 (q < 0.05)
- Cancer dependency (DepMap): dependent in 11.4% of screened cell lines
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.37 (unconstrained)
- MANE Select transcript:
NM_017845
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26036 |
| Approved symbol | COMMD8 |
| Name | COMM domain containing 8 |
| Location | 4p12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ20502 |
| Ensembl gene | ENSG00000169019 |
| Ensembl biotype | protein_coding |
| OMIM | 616656 |
| Entrez | 54951 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay
MANE Select: ENST00000381571
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 2: 1
ENST00000381571, ENST00000509220, ENST00000860334, ENST00000860335, ENST00000860336, ENST00000952424, ENST00001064747, ENST00001134076
RefSeq mRNA: 2 — MANE Select: NM_017845
NM_001329668, NM_017845
CCDS: CCDS3475
Canonical transcript exons
ENST00000381571 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001122055 | 47456577 | 47456729 |
| ENSE00001122065 | 47460144 | 47460299 |
| ENSE00001126666 | 47453059 | 47453214 |
| ENSE00001489158 | 47450787 | 47451665 |
| ENSE00001606759 | 47463586 | 47463702 |
Expression profiles
Bgee: expression breadth ubiquitous, 281 present calls, max score 95.23.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.5612 / max 243.7578, expressed in 1781 samples.
Highest expression (Bgee): choroid plexus epithelium, nephron tubule, monocyte, renal glomerulus, mononuclear cell.
Genetic regulation across tissues (GTEx eQTL / sQTL)
COMMD8 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 16 tissues and its splicing (sQTL) in 5 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 21 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Muscle Skeletal | eqtl | 4.3e-13 | -0.36 | 4:47463352:G:A |
| Esophagus Mucosa | eqtl | 1.6e-06 | -0.15 | 4:47473842:C:A |
| Cells Cultured fibroblasts | sqtl | 3.1e-06 | -0.23 | 4:47449006:A:G |
| Cells EBV-transformed lymphocytes | sqtl | 1.4e-05 | -0.62 | 4:47449006:A:G |
| Whole Blood | eqtl | 7.2e-05 | +0.08 | 4:47876962:C:CAAAT |
| Skin Not Sun Exposed Suprapubic | eqtl | 3.7e-04 | +0.09 | 4:47411505:G:A |
| Artery Tibial | eqtl | 3.1e-03 | +0.12 | 4:47512406:G:A |
| Esophagus Muscularis | eqtl | 3.7e-03 | +0.29 | 4:48186126:C:G |
| Skin Sun Exposed Lower leg | eqtl | 1.0e-02 | -0.34 | 4:47454837:C:T |
| Nerve Tibial | sqtl | 1.0e-02 | +1.02 | 4:47683384:G:A |
| Cells Cultured fibroblasts | eqtl | 1.1e-02 | +0.08 | 4:47420979:G:C |
| Adipose Subcutaneous | eqtl | 1.7e-02 | -0.16 | 4:47093696:G:T |
| Small Intestine Terminal Ileum | eqtl | 2.2e-02 | +0.68 | 4:47671608:G:T |
| Thyroid | eqtl | 2.5e-02 | -0.08 | 4:47333726:C:A |
| Adipose Visceral Omentum | eqtl | 3.0e-02 | +0.43 | 4:46998637:G:A |
| Cells EBV-transformed lymphocytes | eqtl | 3.4e-02 | -0.11 | 4:47414802:G:T |
| Artery Aorta | eqtl | 4.2e-02 | -0.11 | 4:47513172:T:G |
| Esophagus Mucosa | sqtl | 4.7e-02 | -0.73 | 4:46953173:T:C |
| Pancreas | eqtl | 4.7e-02 | +0.54 | 4:46582422:AC:A |
| Lung | eqtl | 4.8e-02 | +0.14 | 4:47543795:T:C |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 52032 | 15.9750 | 1779 |
| 203166 | 0.5862 | 339 |
Top tissues by expression
showing 100 of 288 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| choroid plexus epithelium | UBERON:0003911 | 95.23 | gold quality |
| nephron tubule | UBERON:0001231 | 94.86 | gold quality |
| monocyte | CL:0000576 | 94.65 | gold quality |
| renal glomerulus | UBERON:0000074 | 94.65 | gold quality |
| mononuclear cell | CL:0000842 | 94.62 | gold quality |
| leukocyte | CL:0000738 | 94.37 | gold quality |
| skin of hip | UBERON:0001554 | 94.26 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 94.22 | gold quality |
| oral cavity | UBERON:0000167 | 94.21 | gold quality |
| upper leg skin | UBERON:0004262 | 94.03 | gold quality |
| kidney epithelium | UBERON:0004819 | 93.37 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 93.16 | gold quality |
| calcaneal tendon | UBERON:0003701 | 92.91 | gold quality |
| metanephros | UBERON:0000081 | 92.01 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 91.17 | gold quality |
| bronchial epithelial cell | CL:0002328 | 90.83 | gold quality |
| jejunal mucosa | UBERON:0000399 | 90.81 | gold quality |
| oocyte | CL:0000023 | 90.61 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 90.52 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 90.40 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.27 | gold quality |
| cortex of kidney | UBERON:0001225 | 90.18 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 90.15 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 90.14 | gold quality |
| squamous epithelium | UBERON:0006914 | 90.07 | gold quality |
| secondary oocyte | CL:0000655 | 90.06 | gold quality |
| penis | UBERON:0000989 | 89.68 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.64 | gold quality |
| heart right ventricle | UBERON:0002080 | 89.41 | gold quality |
| kidney | UBERON:0002113 | 89.20 | gold quality |
| rectum | UBERON:0001052 | 89.19 | gold quality |
| islet of Langerhans | UBERON:0000006 | 89.12 | gold quality |
| metanephros cortex | UBERON:0010533 | 89.04 | gold quality |
| tibia | UBERON:0000979 | 88.98 | gold quality |
| vermiform appendix | UBERON:0001154 | 88.59 | gold quality |
| gingiva | UBERON:0001828 | 88.42 | gold quality |
| esophagus mucosa | UBERON:0002469 | 88.36 | gold quality |
| lymph node | UBERON:0000029 | 88.32 | gold quality |
| granulocyte | CL:0000094 | 88.30 | gold quality |
| parietal pleura | UBERON:0002400 | 88.25 | gold quality |
| ileal mucosa | UBERON:0000331 | 88.03 | gold quality |
| pleura | UBERON:0000977 | 87.98 | gold quality |
| gingival epithelium | UBERON:0001949 | 87.95 | gold quality |
| adrenal tissue | UBERON:0018303 | 87.89 | gold quality |
| duodenum | UBERON:0002114 | 87.69 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 87.58 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 87.32 | gold quality |
| visceral pleura | UBERON:0002401 | 87.18 | gold quality |
| corpus epididymis | UBERON:0004359 | 87.10 | gold quality |
| hair follicle | UBERON:0002073 | 87.09 | gold quality |
| bronchus | UBERON:0002185 | 86.98 | gold quality |
| heart left ventricle | UBERON:0002084 | 86.94 | gold quality |
| cardiac ventricle | UBERON:0002082 | 86.86 | gold quality |
| bone marrow | UBERON:0002371 | 86.73 | gold quality |
| colonic mucosa | UBERON:0000317 | 86.71 | gold quality |
| placenta | UBERON:0001987 | 86.70 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 86.44 | gold quality |
| thoracic aorta | UBERON:0001515 | 86.35 | gold quality |
| ascending aorta | UBERON:0001496 | 86.32 | gold quality |
| caecum | UBERON:0001153 | 86.28 | gold quality |
| gall bladder | UBERON:0002110 | 86.25 | gold quality |
| amniotic fluid | UBERON:0000173 | 86.17 | gold quality |
| heart | UBERON:0000948 | 86.17 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 86.06 | gold quality |
| adenohypophysis | UBERON:0002196 | 86.05 | gold quality |
| jejunum | UBERON:0002115 | 85.96 | gold quality |
| right adrenal gland | UBERON:0001233 | 85.89 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 85.85 | gold quality |
| left coronary artery | UBERON:0001626 | 85.77 | gold quality |
| esophagus | UBERON:0001043 | 85.76 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 85.62 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 85.56 | gold quality |
| blood vessel layer | UBERON:0004797 | 85.44 | gold quality |
| nucleus accumbens | UBERON:0001882 | 85.19 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 85.18 | gold quality |
| right atrium auricular region | UBERON:0006631 | 85.18 | gold quality |
| endometrium | UBERON:0001295 | 85.02 | gold quality |
| caudate nucleus | UBERON:0001873 | 84.97 | gold quality |
| left adrenal gland | UBERON:0001234 | 84.88 | gold quality |
| coronary artery | UBERON:0001621 | 84.81 | gold quality |
| aorta | UBERON:0000947 | 84.74 | gold quality |
| pituitary gland | UBERON:0000007 | 84.73 | gold quality |
| synovial joint | UBERON:0002217 | 84.72 | gold quality |
| cardiac atrium | UBERON:0002081 | 84.67 | gold quality |
| pancreas | UBERON:0001264 | 84.64 | gold quality |
| myocardium | UBERON:0002349 | 84.47 | gold quality |
| testis | UBERON:0000473 | 84.43 | gold quality |
| sperm | CL:0000019 | 84.33 | gold quality |
| superficial temporal artery | UBERON:0001614 | 84.33 | gold quality |
| spleen | UBERON:0002106 | 84.26 | gold quality |
| adrenal gland | UBERON:0002369 | 84.25 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 84.13 | gold quality |
| upper arm skin | UBERON:0004263 | 84.07 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 84.04 | gold quality |
| hypothalamus | UBERON:0001898 | 84.01 | gold quality |
| adipose tissue | UBERON:0001013 | 83.95 | gold quality |
| left testis | UBERON:0004533 | 83.92 | gold quality |
| renal medulla | UBERON:0000362 | 83.90 | gold quality |
| cranial nerve II | UBERON:0000941 | 83.90 | gold quality |
| caput epididymis | UBERON:0004358 | 83.90 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.17 |
| E-MTAB-7037 | no | 107.44 |
HPA expression
RNA tissue specificity: Low tissue specificity
showing 60 of 80 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Hippocampal formation | tissue | 77.1 | |
| Cerebral cortex | tissue | 72.2 | medium |
| Retrosplenial and cingulate cortex | tissue | 72.2 | |
| Prefrontal cortex | tissue | 70.1 | |
| Motor cortex | tissue | 68.7 | |
| Entorhinal cortex | tissue | 66.9 | |
| Retrosplenial cortex | tissue | 65.6 | |
| Occipital cortex | tissue | 62.2 | |
| Insular cortex | tissue | 61.9 | |
| Hypothalamus | tissue | 61.2 | |
| Temporal cortex | tissue | 61.1 | |
| Somatosensory cortex | tissue | 59.9 | |
| Septum | tissue | 59.2 | |
| Amygdala | tissue | 55.4 | |
| Pons | tissue | 53.5 | |
| Ventral forebrain | tissue | 52.9 | |
| Periaqueductal gray | tissue | 48.8 | |
| Thalamus | tissue | 48.7 | |
| Basal ganglia | tissue | 45.5 | high |
| Midbrain | tissue | 45.5 | |
| Substantia nigra | tissue | 43.8 | |
| Kidney | tissue | 42.2 | medium |
| Corpus callosum | tissue | 42.2 | |
| Medulla oblongata | tissue | 41.8 | |
| Spinal cord | tissue | 40.0 | |
| Putamen | tissue | 35.3 | |
| Olfactory bulb | tissue | 34.3 | |
| Superior colliculi | tissue | 32.2 | |
| Cerebellum | tissue | 31.1 | high |
| Lymph node | tissue | 28.4 | medium |
| Heart muscle | tissue | 25.4 | high |
| Parathyroid gland | tissue | 25.2 | low |
| Tonsil | tissue | 23.8 | high |
| Esophagus | tissue | 22.7 | medium |
| Testis | tissue | 22.5 | medium |
| Epididymis | tissue | 21.4 | high |
| Thymus | tissue | 20.2 | |
| Bone marrow | tissue | 20.2 | medium |
| Thyroid gland | tissue | 19.9 | medium |
| Appendix | tissue | 19.2 | medium |
| Placenta | tissue | 17.9 | medium |
| Small intestine | tissue | 17.9 | medium |
| Duodenum | tissue | 17.3 | medium |
| Spleen | tissue | 17.0 | medium |
| Rectum | tissue | 16.9 | medium |
| Skin 1 | tissue | 16.6 | high |
| Colon | tissue | 16.6 | medium |
| Urinary bladder | tissue | 15.8 | medium |
| Adrenal gland | tissue | 14.7 | medium |
| Choroid plexus | tissue | 14.1 | |
| Smooth muscle | tissue | 14.0 | low |
| Stomach 1 | tissue | 13.5 | medium |
| Caudate putamen | tissue | 13.3 | |
| Gallbladder | tissue | 12.9 | medium |
| Breast | tissue | 12.7 | high |
| Frontal cortex | tissue | 12.7 | |
| Lung | tissue | 12.7 | medium |
| Pituitary gland | tissue | 12.6 | |
| Adipose tissue | tissue | 12.6 | low |
| Retina | tissue | 12.5 |
Brain sub-regions (HPA Brain Atlas): detected in 192; highest nTPM — Subiculum (77.1), Dorsal hippocampus (75.5), Ventral hippocampus (75.5), White matter (42.2), Dorsal spinal cord (40.0).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting COMMD8 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 67 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-613 | 99.91 | 71.50 | 1710 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-4503 | 99.85 | 71.45 | 1869 |
| HSA-MIR-323A-3P | 99.79 | 70.30 | 1739 |
| HSA-MIR-26A-5P | 99.78 | 73.52 | 2303 |
| HSA-MIR-26B-5P | 99.78 | 73.51 | 2305 |
| HSA-MIR-4465 | 99.71 | 72.56 | 2096 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-4677-5P | 99.70 | 70.09 | 1940 |
| HSA-MIR-7154-5P | 99.69 | 70.52 | 1900 |
| HSA-MIR-3177-5P | 99.65 | 70.38 | 1174 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-7152-5P | 99.60 | 69.33 | 2094 |
Functional genomics
gnomAD constraint: pLI 8.56e-05, LOEUF 1.37, missense Z -0.307 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000381571 — one region, missense o/e 1.03.
DepMap (CRISPR cell-line fitness): dependent in 11.4% of screened cell lines.
Most-dependent cell lines (DepMap gene-effect, lower = stronger; ≤ −0.5 shown): KYAE-1 (-1.121), HuNS1 (-1.104), NCI-H211 (-1.013), DOK (-0.968), Hs 695T (-0.965), YD-38 (-0.929), MAVER-1 (-0.929), LS 180 (-0.901), KLE (-0.879), UPMD1 (-0.879), NB-4 (-0.858), CAL-72 (-0.835), SCCOHT-1 (-0.828), SNU-81 (-0.817), SKN-3 (-0.817).
Literature-anchored findings (GeneRIF, showing 3)
- MNX1-AS1 promoted COMMD8 expression through sponging miR-218-5p. MNX1-AS1 promoted hepatocellular carcinoma progression through activating COMMD8. (PMID:30982576)
- complex determines GRK6 specificity for chemoattractant receptors (PMID:31088898)
- Long noncoding RNA LINC00657 induced by SP1 contributes to the non-small cell lung cancer progression through targeting miR-26b-5p/COMMD8 axis. (PMID:31566716)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | commd8 | ENSDARG00000028201 |
| mus_musculus | Commd8 | ENSMUSG00000029213 |
| rattus_norvegicus | Commd8 | ENSRNOG00000002320 |
Paralogs (2): COMMD7 (ENSG00000149600), COMMD6 (ENSG00000188243)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1343485) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 11 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| decreased IgM level | 1 |
| decreased follicular B cell number | 1 |
| abnormal follicular B cell physiology | 1 |
| decreased mature B cell number | 1 |
| abnormal spleen B cell follicle morphology | 1 |
| decreased spleen germinal center number | 1 |
| decreased IgG1 level | 1 |
| decreased IgG2b level | 1 |
| decreased IgG3 level | 1 |
| decreased IgG2c level | 1 |
| abnormal plasmablast number | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | Q2KIY0 | 88.2% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| MIR8053 | ncRNA | 102467004 |
| CORIN | protein-coding | 10699 |
| ATP10D | protein-coding | 57205 |
| GABRB1 | protein-coding | 2560 |
| COX7B2 | protein-coding | 170712 |
| GABRA4 | protein-coding | 2557 |
Protein
Protein identifiers
COMM domain-containing protein 8 — Q9NX08 (reviewed: Q9NX08)
All UniProt accessions (1): Q9NX08
UniProt curated annotations — full annotation on UniProt →
Function. Scaffold protein in the commander complex that is essential for endosomal recycling of transmembrane cargos; the commander complex is composed of the CCC subcomplex and the retriever subcomplex. May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes. May down-regulate activation of NF-kappa-B.
Subunit / interactions. Component of the commander complex consisting of the CCC subcomplex and the retriever subcomplex. Component of the CCC (COMMD/CCDC22/CCDC93) subcomplex consisting of COMMD1, COMMD2, COMMD3, COMMD4, COMMD5, COMMD6, COMMD7, COMMD8, COMMD9, COMMD10, CCDC22 and CCDC93; within the complex forms a heterodimer with COMMD4. Interacts with RELA, RELB, NFKB1/p105. Interacts with CCDC22, CCDC93, SCNN1B, CUL1, CUL2, CUL3, CUL4A, CUL4B, CUL5.
Subcellular location. Cytoplasm. Nucleus.
Tissue specificity. Widely expressed with highest expression in thyroid.
Similarity. Belongs to the COMM domain-containing protein 8 family.
RefSeq proteins (2): NP_001316597, NP_060315* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR017920 | COMM | Domain |
| IPR047155 | COMMD4/6/7/8 | Family |
| IPR047235 | COMMD8 | Family |
| IPR055184 | COMMD8_HN | Domain |
Pfam: PF07258, PF22838
UniProt features (18 total): helix 9, strand 3, turn 2, chain 1, domain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
3 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 8P0W | Structure of the human Commander complex COMMD ring | ELECTRON MICROSCOPY | 2.9 |
| 8F2R | Human CCC complex | ELECTRON MICROSCOPY | 3.12 |
| 8F2U | Human CCC complex | ELECTRON MICROSCOPY | 3.53 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NX08-F1 | 87.67 | 0.68 |
Human Protein Atlas
Protein class: Predicted intracellular proteins
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): cytosol; nucleoplasm
Antibody reliability (HPA): IH approved · IF supported
Function
Pathways and Gene Ontology
Reactome pathways
1 curated (TAS) of 3; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
3 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-8951664 | Neddylation | curated |
| R-HSA-392499 | Metabolism of proteins | — |
| R-HSA-597592 | Post-translational protein modification | — |
MSigDB gene sets: 133 (showing top):
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GOBP_VESICLE_MEDIATED_TRANSPORT, chr4p12, WEI_MYCN_TARGETS_WITH_E_BOX, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, ROZANOV_MMP14_TARGETS_UP, USF_01, TIEN_INTESTINE_PROBIOTICS_24HR_UP, GOBP_ENDOCYTIC_RECYCLING, USF_02, GOBP_LOCALIZATION_WITHIN_MEMBRANE, ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER, RIGGINS_TAMOXIFEN_RESISTANCE_DN, SENESE_HDAC3_TARGETS_DN, GOCC_MEMBRANE_PROTEIN_COMPLEX
GO Biological Process (3): DNA-templated transcription (GO:0006351), signal transduction (GO:0007165), endocytic recycling (GO:0032456)
GO Molecular Function (2): NF-kappaB binding (GO:0051059), protein binding (GO:0005515)
GO Cellular Component (7): nucleoplasm (GO:0005654), cytosol (GO:0005829), endosome membrane (GO:0010008), protein-containing complex (GO:0032991), nucleus (GO:0005634), cytoplasm (GO:0005737), endoplasmic reticulum membrane (GO:0005789)
Reactome top-level categories
2 top-level categories:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
23 GO namespaces:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| gene expression | 1 |
| RNA biosynthetic process | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| endosomal transport | 1 |
| vesicle-mediated transport to the plasma membrane | 1 |
| RNA polymerase II-specific DNA-binding transcription factor binding | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
| endosome | 1 |
| cytoplasmic vesicle membrane | 1 |
| bounding membrane of organelle | 1 |
| cellular_component | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 3 of 12 annotations. The rest are phylogenetic / computational / electronic (IEA).
3 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| cytosol | CC | direct assay |
| nucleoplasm | CC | direct assay |
| protein-containing complex | CC | direct assay |
Protein interactions and networks
STRING
showing 15 of 1,087 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| COMMD8 | COMMD5 | Q9GZQ3 | 781 |
| COMMD8 | COMMD4 | Q9H0A8 | 773 |
| COMMD8 | COMMD2 | Q86X83 | 772 |
| COMMD8 | COMMD3 | Q9UBI1 | 771 |
| COMMD8 | COMMD6 | Q7Z4G1 | 739 |
| COMMD8 | COMMD9 | Q9P000 | 723 |
| COMMD8 | CCDC22 | O60826 | 717 |
| COMMD8 | COMMD10 | Q9Y6G5 | 697 |
| COMMD8 | COMMD1 | Q8N668 | 675 |
| COMMD8 | CCDC93 | Q567U6 | 671 |
| COMMD8 | COMMD7 | Q86VX2 | 643 |
| COMMD8 | A0A2R8Y455 | A0A2R8Y455 | 643 |
| COMMD8 | DENND10 | Q8TCE6 | 627 |
| COMMD8 | VPS35L | Q7Z3J2 | 600 |
| COMMD8 | GABRB1 | P18505 | 542 |
IntAct
Human interaction partners of COMMD8 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
13 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| CCDC22 | physical association | 0.920 | 1 |
| COMMD1 | physical association | 0.920 | 1 |
| COMMD4 | physical association | 0.880 | 9 |
| CCDC93 | physical association | 0.850 | 1 |
| COMMD3 | physical association | 0.840 | 1 |
| COMMD6 | association | 0.730 | 1 |
| VPS26C | association | 0.640 | 4 |
| ZNF474 | physical association | 0.560 | 3 |
| AKR1C1 | physical association | 0.370 | 1 |
| TMX2 | physical association | 0.370 | 1 |
| CUL1 | association | 0.350 | 1 |
| NFKB1 | association | 0.350 | 1 |
| NDUFA4L2 | physical association | 0.000 | 1 |
BioGRID (143 interactions; top human partners by supporting records): COMMD3 (Affinity Capture-MS; 7 records), CCDC22 (Affinity Capture-MS; 6 records), COMMD1 (Affinity Capture-MS; 6 records), COMMD2 (Co-fractionation; 6 records), COMMD4 (Affinity Capture-MS; 5 records), CCDC93 (Affinity Capture-MS; 4 records), COMMD10 (Affinity Capture-MS; 4 records), COMMD6 (Affinity Capture-MS; 4 records), VPS29 (Affinity Capture-MS; 4 records), C16orf62 (Affinity Capture-MS; 3 records), CCDC151 (Affinity Capture-MS; 3 records), COMMD5 (Co-fractionation; 3 records), COMMD7 (Affinity Capture-MS; 3 records), E2F6 (Affinity Capture-MS; 3 records), TFDP1 (Affinity Capture-MS; 3 records)
Protein complexes (CORUM) (4)
Experimentally-characterized complexes this protein is a subunit of (★ = the complex contains a known drug target).
4 complexes by size:
| Complex | Subunits | Members |
|---|---|---|
| CCC-Wash (WASH1, FAM21C) complex | 15 | COMMD3, COMMD4, CCDC22, COMMD1, COMMD8, WASHC1, WASHC2C, CCDC93, COMMD10, COMMD2, COMMD5, COMMD7, COMMD6, COMMD9, VPS35L |
| CCC complex | 13 | COMMD2, COMMD3, COMMD6, COMMD8, VPS35L, CCDC93, COMMD1, COMMD10, COMMD4, COMMD5, COMMD7, COMMD9, CCDC22 |
| CCDC22-COMMD8-CUL1 complex | 3 | CUL1, CCDC22, COMMD8 |
| Ubiquitin E3 ligase (CCDC22, COMMD8, CUL3) | 3 | CCDC22, COMMD8, CUL3 |
Disease & clinical
Genetic variants
Variant evidence for COMMD8: 40 ClinVar records (0 pathogenic / likely pathogenic); 1 GWAS association.
ClinVar
40 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 28 |
| Likely benign | 5 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 34 predictions of 387):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 4:47453057–47453058 | donor_loss | 1.0000 | 4 |
| 4:47453215–47453216 | acceptor_loss | 1.0000 | 5 |
| 4:47453217–47453219 | acceptor_gain | 1.0000 | 2 |
| 4:47453227 | acceptor_gain | 1.0000 | |
| 4:47456575–47456576 | donor_loss | 1.0000 | 5 |
| 4:47460142–47460143 | donor_loss | 1.0000 | 5 |
| 4:47460300–47460301 | acceptor_loss | 1.0000 | 5 |
| 4:47460305 | acceptor_gain | 1.0000 | |
| 4:47463584–47463585 | donor_loss | 1.0000 | 5 |
| 4:47451667 | acceptor_gain | 0.9900 |
AlphaMissense
244 missense substitutions predicted likely pathogenic (of 1,203 scored), across 85 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| F120 | 8 | 0.823 | 0.971 |
| W122 | 7 | 0.955 | 0.995 |
| R97 | 7 | 0.853 | 0.977 |
| D119 | 7 | 0.829 | 0.904 |
| D131 | 7 | 0.816 | 0.926 |
| E159 | 7 | 0.781 | 0.880 |
| D29 | 7 | 0.751 | 0.829 |
| D121 | 7 | 0.727 | 0.785 |
| M160 | 6 | 0.887 | 0.947 |
| S130 | 6 | 0.885 | 0.982 |
| W46 | 6 | 0.844 | 0.950 |
| W51 | 6 | 0.840 | 0.955 |
| H25 | 6 | 0.713 | 0.759 |
| K125 | 5 | 0.747 | 0.828 |
| P139 | 5 | 0.709 | 0.849 |
| K183 | 4 | 0.835 | 0.887 |
| C93 | 4 | 0.763 | 0.887 |
| S161 | 4 | 0.697 | 0.739 |
| L143 | 3 | 0.977 | 0.987 |
| L117 | 3 | 0.972 | 0.975 |
HPA cancer prognostics
RNA cancer specificity: Low cancer specificity
Human Protein Atlas survival analysis — favorable = higher expression predicts better survival.
3 prognostic cancer types:
| Cancer | Prognostic | p-value |
|---|---|---|
| Kidney Renal Clear Cell Carcinoma (TCGA) | favorable | 3.09e-06 |
| Colon Adenocarcinoma (validation) | favorable | 5.91e-06 |
| Liver Hepatocellular Carcinoma (TCGA) | unfavorable | 3.43e-05 |
Disease associations
OMIM: gene MIM:616656 | disease phenotypes:
GWAS associations
1 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST007323_101 | Risk-taking tendency (4-domain principal component model) | 4e-8 |
EFO canonical traits (from GWAS)
1 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0008579 | risk-taking behaviour |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases methylation, increases expression, affects expression | 5 |
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| cupric chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Diethylstilbestrol | increases expression | 1 |
| Estradiol | affects expression | 1 |
| Gold | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Ivermectin | decreases expression | 1 |
| Quercetin | decreases expression | 1 |
| Aflatoxin B1 | affects expression | 1 |
| Sodium Selenite | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.